Fundz

Galecto, Inc. reported raising $64.2 Million in an initial SEC Form D filing, from an offering of $64.2 Million

PUBLIC · DMRANov 05, 2020

Amount Raised

$64.2 Million

$64.2 Million sold, per SEC Form D (first sale Nov 5, 2020)

Round Type

Venture

WalthamBiotechnologyHealthcareHealth CareMedicalTherapeutics

Quick answer

Damora Therapeutics, Inc. raised $64.2 Million in a funding round, dated November 5, 2020. Damora Therapeutics, Inc. is based in Waltham, Massachusetts, United States.

How much did Damora Therapeutics, Inc. raise?
Damora Therapeutics, Inc. raised $64.2 Million in a funding round on November 5, 2020.
What does Damora Therapeutics, Inc. do?
Galecto is a clinical-stage biotechnology company developing novel small-molecule therapeutics that target the core biological drivers of fibrosis, inflammation, and cancer.
Where is Damora Therapeutics, Inc. based and how big is it?
Damora Therapeutics, Inc. is based in Waltham, Massachusetts, United States. Fundz records about 18 employees.
Who are the decision-makers at Damora Therapeutics, Inc?
Fundz holds 2 contacts at Damora Therapeutics, Inc., including the Chief Financial Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Medical around the same time

Companies in the same sectors as Damora Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Elevation Oncology raised $65M on November 18, 2020.
  • Lipella Pharmaceuticals raised $405K (Seed) on November 4, 2020.
  • TuHURA Biosciences raised $2.7M (Seed) on December 17, 2020.
  • CytoDyn raised $1M (Seed) on December 16, 2020.
  • CytoDyn raised an undisclosed amount on December 16, 2020.
  • Scorpion Therapeutics raised $147M on December 7, 2020.

Who to call at Damora Therapeutics, Inc., and when

A new round usually means Damora Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Damora Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Damora Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Damora Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Damora Therapeutics, Inc.

Location

Waltham, Massachusetts, United States

About

Galecto is a clinical-stage biotechnology company developing novel small-molecule therapeutics that target the core biological drivers of fibrosis, inflammation, and cancer. Founded by leading scientists and biotech executives with more than a decade of research into galectin biology and LOXL2 modulation, the company has built deep expertise in pathways central to complex and often devastating diseases. Galecto is backed by prominent investors including Novo Holdings, OrbiMed, Ysios, HBM Healthcare Investments, Sunstone Capital, M Ventures, Bristol-Myers Squibb, Maverick Ventures, Seventure, and SEED Capital.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Damora Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsLori F., Chief Financial Officer hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Damora Therapeutics, Inc.'s next move

See what Strategic adds

Damora Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.